| Joon-hyung Kim, MD | |
|
223 N Van Dien Ave, Ridgewood, NJ 07450-2726 | |
| (201) 847-9320 | |
| Not Available |
| Full Name | Joon-hyung Kim |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 11 Years |
| Location | 223 N Van Dien Ave, Ridgewood, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417214685 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 25MA10715400 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Valley Hospital | Ridgewood, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bergen Anesthesia Group, P.c. | 6608861794 | 50 |
News Archive
Professor Sue Jordan from the University's College of Human and Health Science, who led the study, says the findings could be used to help clinicians improve care for women during pregnancy and after they have given birth.
Today's coverage includes more details regarding how the new health law moves forward with efforts to provide health insurance coverage to young adults.
Thanks to important discoveries in basic and clinical research and technological advances, the fight against cancer has mobilized into a complex offensive spanning multiple fronts.
Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.
› Verified 6 days ago
| Entity Name | Bergen Anesthesia Group, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194816249 PECOS PAC ID: 6608861794 Enrollment ID: O20040419000098 |
News Archive
Professor Sue Jordan from the University's College of Human and Health Science, who led the study, says the findings could be used to help clinicians improve care for women during pregnancy and after they have given birth.
Today's coverage includes more details regarding how the new health law moves forward with efforts to provide health insurance coverage to young adults.
Thanks to important discoveries in basic and clinical research and technological advances, the fight against cancer has mobilized into a complex offensive spanning multiple fronts.
Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joon-hyung Kim, MD Po Box 629, Franklin Lakes, NJ 07417-0629 Ph: (201) 847-9320 | Joon-hyung Kim, MD 223 N Van Dien Ave, Ridgewood, NJ 07450-2726 Ph: (201) 847-9320 |
News Archive
Professor Sue Jordan from the University's College of Human and Health Science, who led the study, says the findings could be used to help clinicians improve care for women during pregnancy and after they have given birth.
Today's coverage includes more details regarding how the new health law moves forward with efforts to provide health insurance coverage to young adults.
Thanks to important discoveries in basic and clinical research and technological advances, the fight against cancer has mobilized into a complex offensive spanning multiple fronts.
Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.
› Verified 6 days ago
Erik Wohlfarth, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 223 N Van Dien Ave, Ridgewood, NJ 07450 Phone: 201-847-9320 | |
Evelyn Bae, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 223 N Van Dien Ave, Ridgewood, NJ 07450 Phone: 201-847-9320 | |
Jennifer Souh, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 223 N Van Dien Ave, Ridgewood, NJ 07450 Phone: 201-847-9320 | |
Dr. John P Lee, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 223 N Van Dien Ave, Ridgewood, NJ 07450 Phone: 201-447-8000 | |
Dr. Joseph Michael Aloi, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 223 N Van Dien Ave, Ridgewood, NJ 07450 Phone: 201-447-8000 | |
Dr. Richard F Iannacone, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Valley Hospital, 233 Van Dien Ave, Ridgewood, NJ 07450 Phone: 201-447-8000 | |
Dr. Thomas Johnson, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 223 N Van Dien Ave, Ridgewood, NJ 07450 Phone: 201-847-9320 |